As of close of business last night, Editas Medicine Inc’s stock clocked out at $7.28, down -1.89% from its previous closing price of $7.42. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 1246510 shares were traded.
Ratios:
To gain a deeper understanding of EDIT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.
On October 18, 2023, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when O’Neill Gilmore Neil sold 77,824 shares for $9.42 per share. The transaction valued at 732,884 led to the insider holds 327,470 shares of the business.
Mei Baisong sold 20,327 shares of EDIT for $191,425 on Mar 04 ’24. The SVP, CHIEF MEDICAL OFFICER now owns 141,543 shares after completing the transaction at $9.42 per share. On Dec 05 ’23, another insider, Eaton Bruce, who serves as the EVP, CBO AND CTO of the company, sold 103 shares for $10.90 each. As a result, the insider received 1,122 and left with 74,791 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 595.60M and an Enterprise Value of 309.03M. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.62 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 3.96 whereas that against EBITDA is -1.89.
Stock Price History:
Over the past 52 weeks, EDIT has reached a high of $11.91, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is 8.10, while the 200-Day Moving Average is calculated to be 8.57.
Shares Statistics:
It appears that EDIT traded 1.85M shares on average per day over the past three months and 2.28M shares per day over the past ten days. A total of 81.77M shares are outstanding, with a floating share count of 80.82M. Insiders hold about 1.22% of the company’s shares, while institutions hold 73.22% stake in the company. Shares short for EDIT as of Mar 15, 2024 were 13.93M with a Short Ratio of 7.53, compared to 12.59M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 17.02% and a Short% of Float of 23.92%.
Earnings Estimates
As of right now, 15 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.66 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$1.09, while EPS last year was -$0.71. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.46 and low estimates of -$1.11.
Analysts are recommending an EPS of between -$1.84 and -$3.83 for the fiscal current year, implying an average EPS of -$2.65. EPS for the following year is -$2.67, with 16 analysts recommending between -$1.71 and -$4.51.
